CD47 and brain neoplasm: CD47 is overexpressed by malignant cells to evade the innate immune response and may be particularly enriched in pediatric brain tumors including medulloblastoma, acute teratoid rhabdoid tumor, pediatric glioblastoma, and DIPG [69].